ArticleMolecules (Basel, Switzerland)2025
Beneficial Effects of Grape Pomace Extract on Hyperglycemia, Dyslipidemia, and Oxidative Stress in Experimental Diabetes Mellitus.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Grape pomace, a polyphenol-rich byproduct of wine production, represents a promising source of bioactive compounds for managing diabetes and its complications. This study evaluates the effect of a novel grape pomace extract on carbohydrate and lipid metabolism, and oxidative stress in type 1 diabetes mellitus. Diabetes was induced in male Wistar rats by a single intraperitoneal injection of streptozotocin. Starting on day 14 post-induction, rats received oral grape pomace extract at a dose of 45 mg of polyphenols/kg body weight daily for 14 days. On day 28 of the experiment, blood plasma was collected. One-way ANOVA with post hoc testing revealed a hypoglycemic effect of grape pomace extract, as evidenced by reduced fasting blood glucose and improved postprandial glycemic responses. The extract also ameliorated dyslipidemia, lowering total cholesterol and triglycerides while increasing high-density lipoprotein levels and paraoxonase activity in plasma of diabetic rats. Antioxidant defenses were enhanced, as indicated by elevated superoxide dismutase, catalase, and glutathione peroxidase activities, along with reduced protein carbonyls, TBA-reactive products, and lipofuscin in blood plasma following extract administration. These findings demonstrate the metabolic and antioxidant potential of grape pomace polyphenols, although further investigations are needed to elucidate the underlying molecular mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.